Saturday, 19 May 2018

Have your say on the big NHS England MS debate?

You may be aware that NHS England has just closed the public consultation period for the new NHS England Treatment MS DMT Algorithm. The aim of the algorithm is part of a troika, along with Blueteq and MDTs (multidisciplinary team meetings) to reduce the variation in prescribing of DMTs across England. The question is will this algorithm achieve its aim?

The following is the debate we had on this topic last week at the ABN in Birmingham. Please have your say; watch the debate and vote.


1 comment:

  1. "with Blueteq and MDTs (multidisciplinary team meetings)"

    Sounds like hiding behind gobblygook terms to try to justify


Please note that all comments are moderated and any personal or marketing-related submissions will not be shown.